Use access key #2 to skip to page content.
$3.43 0.12 (3.63%)
7/3/2008 1:00 PM

ACADIA Pharmaceuticals, Inc. (ACAD)

CAPS Rating:
*

The Company is a biopharmaceutical company focused on the discovery, development, and commercialization of small molecule drugs for the treatment of central nervous system disorders.

View All Commentary (ACAD)

Recs

0

Avatar sdpowell (37.47) Submitted: 10/29/07 6:44 PM : Outperform Start Price: $15.16 ACAD Score: -59.69

huge potential for the drugs they offer, good chance of being acquired by a large company too

Report this Post Replies: 0 | Reply

Featured Broker Partners